Deal facts
- Buyer
- Circle Health Holdings Limited
- Target
- CHC Healthcare Holdings Limited
- Deal value
- Not disclosed
- Announced
- Not stated
- Status
- Completed
- Sector
- Healthcare
- Country
- United Kingdom
- Consideration
- Not stated
Sources
Circle Health Holdings Limited has agreed to acquire CHC Healthcare Holdings Limited in a strategic acquisition within the healthcare sector. Both entities are based in the United Kingdom, with the buyer operating as a UK-based organisation. The transaction involves the transfer of ownership from the target to the acquiring group, marking a consolidation of assets within the domestic market. No specific financial consideration or deal value was disclosed in the available records, and the exact date of announcement remains unreported.
The transaction has been completed, indicating that the legal and operational transfer of the business has concluded. Regulatory approvals and other standard conditions required for the deal have been satisfied to finalise the acquisition. This move represents a significant development for the healthcare landscape in the region, bringing the target company under the control of the established buyer. The deal stands as a completed strategic acquisition without further public updates on integration plans or future operational changes.
More M&A Tools
Explore the Toolkit
Tools, frameworks and AI assistants designed for entrepreneurs serious about M&A.
Access nowDeal timeline
1 update- CompletedClosed
Circle Health / BMI Healthcare: Review of undertakings
The CMA is reviewing the undertakings in lieu of a reference relating to the completed acquisition by Circle Health Holdings Limited of all the issued share capital of CHC Healthcare Holdings Limited. Administrative timetable Any revisions made to the timetable will be published on this webpage. Date Action 2 May 2024 Publish final decisions November 2021 Publish
UK CMA
Explore
Browse adjacent archives
Jump from this deal into the sector, buyer, deal type, and year views that carry the strongest contextual signal.
Similar deals
Similar deals
Other Healthcare M&A activity tracked by Exit Mode.
Cronos Group Inc. to acquire CanAdelaar B.V.
Cronos Group Inc. has agreed to acquire CanAdelaar B.V. in a strategic acquisition within the healthcare sector. The Canadian buyer will purchase the Dutch target for a…
- Buyer
- Cronos Group Inc.
- Target
- CanAdelaar B.V.
- Deal value
- EUR 57,500,000
- Deal type
- strategic acquisition
Alaunos Therapeutics, Inc. to acquire Velaris Therapeutics, Inc.
Alaunos Therapeutics, Inc. has agreed to acquire Velaris Therapeutics, Inc. in a strategic acquisition. The transaction was announced on 13 October 2026 and was complete…
- Buyer
- Alaunos Therapeutics, Inc.
- Target
- Velaris Therapeutics, Inc.
- Deal value
- Not disclosed
- Deal type
- strategic acquisition
STERIS Corporation to acquire Xodus Medical, Inc.
STERIS Corporation has agreed to acquire Xodus Medical, Inc. in a strategic transaction valued at two billion US dollars. The healthcare deal was announced on 11 October…
- Buyer
- STERIS Corporation
- Target
- Xodus Medical, Inc.
- Deal value
- USD 2,100,000,000
- Deal type
- strategic acquisition
Hepion Pharmaceuticals, Inc. to acquire Gravitas Life Sciences, LLC
Hepion Pharmaceuticals, Inc. has agreed to acquire Gravitas Life Sciences, LLC in a strategic acquisition. The transaction, valued at 4.25 million US dollars, was comple…
- Buyer
- Hepion Pharmaceuticals, Inc.
- Target
- Gravitas Life Sciences, LLC
- Deal value
- USD 4,250,000
- Deal type
- strategic acquisition
BC PARTNERS to acquire ACS DOBFAR
BC PARTNERS has agreed to acquire ACS DOBFAR in a strategic acquisition within the healthcare sector. The transaction was announced on 8 October 2026. No specific financ…
- Buyer
- BC PARTNERS
- Target
- ACS DOBFAR
- Deal value
- Not disclosed
- Deal type
- strategic acquisition
Buyer history
Circle Health Holdings Limited
See every published Exit Mode archive entry where this buyer appears.
View buyer profileMethodology
How this page is built
Layer 1 facts come from source documents, Layer 2 turns those facts into a readable narrative, and Layer 3 only appears where the editorial team flags a founder-relevant deal.
Back to the archive